title: ASHP therapeutic position statement on strategies for identifying and preventing pneumococcal resistance.
abstract: The incidence of MDRSP continues to increase, causing significant morbidity and mortality. Health care providers should seize the opportunity to promote the judicious use of antimicrobials and vaccinate patients with the pneumococcal vaccines as a means to lessen this significant health problem. Pharmacists are poised to play a key role in patient care by assessing for the need and administering vaccines in compliance with the current guidelines. A pharmacist should have a key role on the antimicrobial stewardship team.
authors.affiliation: Kimberly A. Couch, Pharm.D., M.A., FIDSA, FASHP, is President, Infectious Diseases Pharmacy Associates, Stevensville, MD, and Clinical Pharmacist, Complete Rx, Seaford, DE. Teresa Geide, Pharm. D., BCPS, CGP, is Clinical Pharmacy Specialist, Infectious Diseases, Orlando Veterans Affairs Medical Center, Orlando, FL.
authors.forename: Kimberly A
authors.initials: KA
authors.lastname: Couch
authors.forename: Teresa
authors.initials: T
authors.lastname: Geide
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial / Q000235:genetics; D006801:Humans; D008826:Microbial Sensitivity Tests; D010595:Pharmacists; D011008:Pneumococcal Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology*; D022242:Pneumococcal Vaccines / Q000627:therapeutic use; D062486:Public Health Surveillance; D018570:Risk Assessment; D012957:Societies, Pharmaceutical; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000235:genetics; D014611:Vaccination
chemical_list: D000900:Anti-Bacterial Agents; D022242:Pneumococcal Vaccines